The Prospects for Red-Cell Substitutes
- 1 June 2000
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (22) , 1666-1668
- https://doi.org/10.1056/nejm200006013422211
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Transfusions of Polymerized Bovine Hemoglobin in a Patient with Severe Autoimmune Hemolytic AnemiaNew England Journal of Medicine, 2000
- Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic ShockA Randomized Controlled Efficacy TrialJAMA, 1999
- The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modelingTransfusion, 1999
- Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage modelJournal of Applied Physiology, 1998
- The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgeryJournal of the American College of Surgeons, 1998
- Human Cardiovascular and Metabolic Response to Acute, Severe Isovolemic AnemiaJAMA, 1998
- Ethical Complexities of Conducting Research in Developing CountriesNew England Journal of Medicine, 1997
- Safety of the blood supplyPublished by American Medical Association (AMA) ,1995
- Fluosol-DA as a Red-Cell Substitute in Acute AnemiaNew England Journal of Medicine, 1986